Chris Smith

Chris is an experienced Investment Manager at Brandon Capital Partners, where he is involved in conducting seed and venture capital investments for the development and international growth of Australian life science companies. Chris also has extensive experience with both the in-licensing and out-licensing of therapeutic drugs and R&D platforms, which he gained as a Business Development Manager with CSL Ltd., Australia’s largest pharmaceutical company. At CSL, Chris was also responsible for identifying and reviewing opportunities for the global R&D pipeline.

Chris has a PhD in immunology conducted at the Walter and Eliza Hall Institute, and an MBA specialising in innovation and entrepreneurship from the University of Cambridge.